References
- ZhuHWangZMaCNeuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studiesPlanta Med200369542943312802724
- ZhuHBWangZHTianJWFuFHLiuKLiCLProtective effect of hydroxysafflor yellow A on experimental cerebral ischemia in ratsYao Xue Xue Bao200540121144114616496682
- LiuYNZhouZMChenPEvidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore openingClin Exp Pharmacol Physiol200835221121617941891
- WangSSunMPingQEnhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in ratsInt J Pharm20083581–219820418417306
- QinFHuangXGuanxin II (II) for the management of coronary heart diseaseChin J Integr Med200915647247620082256
- LiuSXZhangYWangYFUpregulation of heme oxygenase-1 expression by hydroxysafflor yellow A conferring protection from anoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytesInt J Cardiol4142011 [Epub ahead of print.]
- WangJChowDHeiatiHShenWCReversible lipidization for the oral delivery of salmon calcitoninJ Control Release200388336938012644363
- KogaKTakaradaNTakadaKNano-sized water-in-oil-in-water emulsion enhances intestinal absorption of calcein, a high solubility and low permeability compoundEur J Pharm Biopharm201074222323219755156
- QiXWangLZhuJWater-in-oil-in-water double emulsions: an excellent delivery system for improving the oral bioavailability of pidotimod in ratsJ Pharm Sci201110062203221121491444
- LutzRAserinAWickerLGartiNRelease of electrolytes from W/O/W double emulsions stabilized by a soluble complex of modified pectin and whey protein isolateColloids Surf B Biointerfaces200974117818519683899
- QiXWangLZhuJHuZZhangJSelf-double-emulsifying drug delivery system (SDEDDS): a new way for oral delivery of drugs with high solubility and low permeabilityInt J Pharm20114091–224525121356300
- TakatsukaSMoritaTKoguchiAHorikiriYYamaharaHYoshinoHSynergistic absorption enhancement of salmon calcitonin and reversible mucosal injury by applying a mucolytic agent and a non-ionic surfactantInt J Pharm20063161–212413016600541
- TianYYangZFLiYPharmacokinetic comparisons of hydroxysafflower yellow A in normal and blood stasis syndrome ratsJ Ethnopharmacol201012911420206677
- CornaireGWoodleyJHermannPCloarecAArellanoCHouinGImpact of excipients on the absorption of p-glycoprotein substrates in vitro and in vivoInt J Pharm2004278111913115158955
- LinYShenQKatsumiHEffects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a p-glycoprotein substrate, in ratsBiol Pharm Bull20073071301130717603171
- RegeBDKaoJPPolliJEEffects of nonionic surfactants on membrane transporters in Caco-2 cell monolayersEur J Pharm Sci2002164–523724612208453
- ShaXYanGWuYLiJFangXEffect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cellsEur J Pharm Sci200524547748615784337
- YehPYSmithPLEllensHEffect of medium-chain glycerides on physiological properties of rabbit intestinal epithelium in vitroPharm Res1994118114811547971716